EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
5 hedge funds and large institutions have $2.98M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
-33
Holders Change %
-86.84%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
34
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$219K |
Top Sellers
| 1 |
GCL
Glazer Capital LLC
New York
|
-$10.2M |
| 2 |
DM
Deerfield Management
New York
|
-$10M |
| 3 |
BlackRock
New York
|
-$9.02M |
| 4 |
D.E. Shaw & Co
New York
|
-$6.68M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$6.53M |
